Suppr超能文献

正常血脂受试者中与高密度脂蛋白相关的载脂蛋白A-IV和A-I的体内代谢

In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects.

作者信息

Malmendier C L, Lontie J F, Lagrost L, Delcroix C, Dubois D Y, Gambert P

机构信息

Fondation de Recherche sur l'Athérosclérose, Brussels, Belgium.

出版信息

J Lipid Res. 1991 May;32(5):801-8.

PMID:1906522
Abstract

The kinetics of apolipoprotein A-IV associated with high density lipoproteins (HDL) of plasma from fasting human subjects was followed for 15 days in five healthy normolipidemic volunteers. Purified apoA-IV and apoA-I were radioiodinated, respectively, with 125I and 131I, incubated in vitro with normal HDL, isolated at density 1.250 g/ml, and finally reinjected intravenously as HDL-125I-labeled apoA-IV and HDL-131I-labeled apoA-I. Blood samples were withdrawn at regular intervals for 15 days, and 24-h urine samples were collected. More than 93% (93.5 +/- 0.9%) of apoA-IV was recovered in apoA-I-containing lipoprotein particles after affinity chromatography on an anti-apoA-I column and 69.7 +/- 4.8% was bound to apoA-II in apoA-I:A-II particles separated on an anti-apoA-II column. 125I-labeled apoA-IV showed a much faster decay than 131I-labeled apoA-I for the first 5 days and thereafter the curves became parallel. Urinary/plasma ratios (U/P) for the 125I-labeled parallel. Urinary/plasma ratios (U/P) for the 125I-labeled apoA-IV were much higher than those for 131I-labeled apoA-I for the first days, but the U/P curves became parallel for the last 7 days, suggesting heterogeneity of apoA-IV metabolism. A heterogeneous multicompartmental model was constructed to describe the metabolism of lipoprotein particles containing apoA-IV and apoA-I and to calculate the kinetic parameters, fitting simultaneously all plasma and urine data for both tracers.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在五名健康的血脂正常志愿者中,对空腹人类受试者血浆中与高密度脂蛋白(HDL)相关的载脂蛋白A-IV的动力学进行了为期15天的追踪研究。分别用125I和131I对纯化的载脂蛋白A-IV和载脂蛋白A-I进行放射性碘化,在体外与密度为1.250 g/ml的正常HDL一起孵育,最后作为HDL-125I标记的载脂蛋白A-IV和HDL-131I标记的载脂蛋白A-I静脉再注射。在15天内定期采集血样,并收集24小时尿样。在抗载脂蛋白A-I柱上进行亲和层析后,超过93%(93.5±0.9%)的载脂蛋白A-IV在含载脂蛋白A-I的脂蛋白颗粒中被回收,在抗载脂蛋白A-II柱上分离的载脂蛋白A-I:载脂蛋白A-II颗粒中,69.7±4.8%与载脂蛋白A-II结合。在最初5天,125I标记的载脂蛋白A-IV的衰减比131I标记的载脂蛋白A-I快得多,此后曲线变得平行。125I标记的载脂蛋白A-IV的尿/血浆比值(U/P)在最初几天远高于131I标记的载脂蛋白A-I,但在最后7天U/P曲线变得平行,提示载脂蛋白A-IV代谢存在异质性。构建了一个异质性多室模型来描述含载脂蛋白A-IV和载脂蛋白A-I的脂蛋白颗粒的代谢,并计算动力学参数,同时拟合两种示踪剂的所有血浆和尿液数据。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验